Stock data

禾榮科 (7799)

禾榮科 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$1.10M, down 27.0% from a year earlier. EPS over the last four quarters totals -NT$3.17.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 禾榮科 in Insightr